Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Frank

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Pharmacology|February 16, 2006
Hyperforin in St. John's wort drug interactionsRajanikanth Madabushi, Bruno Frank, Bernd Drewelow, et al.
Scientia Pharmaceutica|May 28, 2011
Preparation of herbal tea as infusion or by maceration at room temperature using mistletoe tea as an exampleSebastian Jäger, Markus Beffert, Katharina Hoppe, et al.
Phytotherapy Research : PTR|March 1, 2022
Antiviral activity of plant juices and green tea against SARS-CoV-2 and influenza virusMaren Eggers, Peggy Jungke, Volker Wolkinger, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interactionIngrid Mai, Steffen Bauer, Elke S Perloff, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
Effect of St John's wort dose and preparations on the pharmacokinetics of digoxinSilke C Mueller, Bernhard Uehleke, Heike Woehling, et al.
European Journal of Clinical Pharmacology|December 13, 2005
The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin doseSilke C Mueller, Jolanta Majcher-Peszynska, Bernhard Uehleke, et al.
European Journal of Clinical Pharmacology|September 3, 2008
No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteersSilke C Mueller, Jolanta Majcher-Peszynska, Ralf G Mundkowski, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Pharmacology|February 16, 2006
Hyperforin in St. John's wort drug interactionsRajanikanth Madabushi, Bruno Frank, Bernd Drewelow, et al.
Scientia Pharmaceutica|May 28, 2011
Preparation of herbal tea as infusion or by maceration at room temperature using mistletoe tea as an exampleSebastian Jäger, Markus Beffert, Katharina Hoppe, et al.
Phytotherapy Research : PTR|March 1, 2022
Antiviral activity of plant juices and green tea against SARS-CoV-2 and influenza virusMaren Eggers, Peggy Jungke, Volker Wolkinger, et al.
Clinical Pharmacology and Therapeutics|October 8, 2004
Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interactionIngrid Mai, Steffen Bauer, Elke S Perloff, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
Effect of St John's wort dose and preparations on the pharmacokinetics of digoxinSilke C Mueller, Bernhard Uehleke, Heike Woehling, et al.
European Journal of Clinical Pharmacology|December 13, 2005
The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin doseSilke C Mueller, Jolanta Majcher-Peszynska, Bernhard Uehleke, et al.
European Journal of Clinical Pharmacology|September 3, 2008
No clinically relevant CYP3A induction after St. John's wort with low hyperforin content in healthy volunteersSilke C Mueller, Jolanta Majcher-Peszynska, Ralf G Mundkowski, et al.
Pageof 1